STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 101 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $43,000 | -61.3% | 8,927 | -14.8% | 0.00% | – |
| Q4 2019 | $111,000 | +22.0% | 10,472 | +20.2% | 0.00% | – |
| Q3 2019 | $91,000 | -25.4% | 8,714 | +9.2% | 0.00% | – |
| Q2 2019 | $122,000 | +28.4% | 7,982 | +7.3% | 0.00% | – |
| Q1 2019 | $95,000 | +90.0% | 7,442 | +41.8% | 0.00% | – |
| Q4 2018 | $50,000 | -27.5% | 5,249 | +27.1% | 0.00% | – |
| Q3 2018 | $69,000 | +4.5% | 4,129 | 0.0% | 0.00% | – |
| Q2 2018 | $66,000 | -8.3% | 4,129 | -12.1% | 0.00% | – |
| Q1 2018 | $72,000 | -20.0% | 4,695 | -20.4% | 0.00% | – |
| Q4 2017 | $90,000 | +104.5% | 5,895 | +49.2% | 0.00% | – |
| Q3 2017 | $44,000 | +22.2% | 3,951 | 0.0% | 0.00% | – |
| Q2 2017 | $36,000 | +63.6% | 3,951 | +52.2% | 0.00% | – |
| Q1 2017 | $22,000 | -29.0% | 2,596 | -11.8% | 0.00% | – |
| Q4 2016 | $31,000 | – | 2,943 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 220,000 | $9,965,000 | 0.68% |
| Healthcare Value Capital, LLC | 16,464 | $746,000 | 0.65% |
| EAM Investors, LLC | 69,151 | $3,132,000 | 0.62% |
| Baker Brothers Advisors | 800,400 | $36,255,000 | 0.52% |
| Spark Investment Management LLC | 38,300 | $1,733,000 | 0.40% |
| Perceptive Advisors | 180,416 | $8,172,000 | 0.34% |
| SIGMA CAPITAL MANAGEMENT LLC | 175,000 | $7,926,000 | 0.33% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 129,915 | $5,885,000 | 0.23% |
| Visium Asset Management, LP | 150,000 | $6,794,000 | 0.15% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 19,732 | $894,000 | 0.14% |